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Case Report
Dengue Fever with Hepatitis E and Hepatitis A infection
Javed Yakoob, Wasim Jafri, Shaheer Siddiqui, Mehmood Riaz
Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan.

Abstract
Infection with dengue viruses produces a spectrum of
clinical illness ranging from a nonspecific viral syndrome to
severe and fatal haemorrhagic disease. Important risk factors
include the strain and serotype of the infecting virus, as well as
the age, immune status, and genetic predisposition of the
patient. The teaching point in this case study was Dengue fever
which occurred concomitantly with Hepatitis A and Hepatitis E
virus infection.

Introduction
Jaundice follows due to a variety of causes including
hepatitis A, B, C, D, and E viral infections, alcohol abuse,
medications and toxins. Hepatitis E virus (HEV) and hepatitis A
virus (HAV) are endemic in South Asia.1 Dengue fever (DF) is
a mosquito-borne virus infection, caused by four distinct viruses
(serotypes 1 to 4) that are closely related antigenically. Dengue
virus serotype 3 is responsible for most of the DF cases in
Karachi, Pakistan.2 There is no treatment of Dengue fever (DF).
However, dengue fever shock syndrome requires a supportive
treatment.3

Case Report
A 17 year old girl was admitted in September 2007 with
jaundice for one month associated with fever for ten days and
altered consciousness since one day. There was no significant
past history. Patient had paracetamol and antimalarials for the
last ten days. On examination, she was jaundiced and drowsy;
Glasgow coma scale (GCS) was 8/15 with a pulse 108/min,
blood pressure 109/73 mm Hg and temperature of 102ºF.
Systemic examination was normal, besides a palpable spleen.
The labs on admission demonstrated a haemoglobin of 10
(range 11.1-14.5) gm/dl, haematocrit 34.3% (range 35.4-42.0),
white cell count 3.2 (range 2.0-10.0) with neutrophil 84%
(range 40-75), platelet 183 x109/L (range 150-400); malarial
parasite was not seen on film; prothrombin time (PT) 23 (range
10-15 seconds), activated plasma thrombin time (APTT) 38.4
sec(range 25-35 seconds), bilirubin 22 (range 0.25-1.0) mg/dl,
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alanine transaminase (ALT) 330 (range 3-33) I.U/L, aspartate
transaminase (AST) 220 (range 18-32) I.U/L; alkaline
phosphatase (ALP) 518 (range 31-141) I.U/L, gamma
glutamate transaminase (GGT) 33 (range 1-37) I.U/L, sodium
127 (range 136-148) mmol/L, potassium 2.5 mg (range 3.6-5.0)
mmol/L, albumin 1.9 g/dl, serum amylase 125 (range 25-125)
U/L, lactic dehydrogenase (LDH) 705 mg, magnesium 1.8
(range 1.9-2.5) mg/dl. Plasmodium falciparum and Plasmodium
Viva were negative by immunochromatographic test (ICT)
detecting malaria antigen. She was admitted in intensive care
unit for grade III Hepatic encephalopathy and treated with IV
fluid and lactulose. She stabilized haemodynamically over next
two days and her WBC count reduced to 15.3, PT 27, ALT 59,
K 3.0 mmol/L. Patient recovered from Hepatic encephalopathy
after 4 days. Serology was positive for HEV and HAV IgM
antibodies. Hepatitis B virus s Antigen (HBsAg), Hepatitis B
core IgM, Hepatitis C virus antibody and HEV virus IgG were
negative. Her chest x-ray and abdominal ultrasound were
normal. Blood cultures were negative. Antinuclear antibody,
anti-smooth muscle antibody and anti-mitochondrial antibody
screen were negative but Coomb's test was positive. Serum
ceruloplasmin and Urinary copper were in the normal range.
She was discharged home after two days after being stabilized,
on steroids, proton pump inhibitor and folic acid for haemolytic
anemia. Patient’s serology for DF IgM was positive.

Discussion
In this case, the dengue infection occurred concurrently
while the patient was also suffering from HEV and HAV. Antidengue IgM detectable by IgM antibody capture enzyme-linked
immunosorbent assay (MAC-ELISA) appears in half of the
patients with a primary infection while they are still febrile; in
the other half, it appears within 2-3 days of defervescence.4
Anti-dengue IgM levels are detectable in about 30% of patients
2 months after the onset of symptoms.5 In this case, also, dengue
fever was positive on repeating the test. This is a common
observation by physicians actively involved in the management
of patients with dengue fever.5 Symptoms and signs of dengue
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infection, especially during the acute phase of illness, are
difficult to distinguish from other diseases such as malaria and
typhoid, which were negative in this case.6 This patient also had
a positive Coomb's test which is known to be associated with
acute HEV, HAV and DV infection.
Dengue fever is one of the serious emerging infection in
several cities of Pakistan.2 There are previous case reports of DF
occurring concomitantly with other viral, bacterial and parasitic
infections.6 The cases of DF occur in the months immediately
following rainy seasons. It is known that detectable levels of
anti-dengue antibodies appear after several days of fever.
Persons never previously infected with a flavivirus, nor
immunized with a flavivirus vaccine, show a primary antibody
response when infected with a dengue virus. Once detectable,
IgM levels rise quickly and appear to peak about 2 weeks after
the onset of symptoms, anti-dengue IgG appears afterwards.
Anti-dengue IgM is conclusive for a recent dengue infection.4
The cells of macrophage-lineage, interstitial dendritic
cells (DC) and Langerhan cell (LC) constitute the first line of
the innate host defense against invading DV in skin where it
replicates after the initial bite by infected mosquito.
Macrophages are the principal cells to replicate DV which
impairs their function and increases severity of the damage to
the body.7 The impact of DV infection on innate immunity is the
determining factor. Early activation of natural killer (NK) cells
and type-I interferon dependent immunity may limit viral
replication at the early stages of DV infection.8 A successful
challenge to virus infection requires that a balance between the
induction of efficient anti-viral effector mechanisms and the
avoidance of detrimental tissue damage. The increased level of
progesterone and estrogens in women are also known to directly
influence viral replication and viral gene expression through
their effects on viral regulatory elements.8 The potential risk
factor for enhanced viral replication/expression in women,
include malnutrition and folate deficiency which increases the
incidence of the multiple viral infection and/or increased viral
load.9 A selective high susceptibility could be associated with
the genes of the major histocompatibility complex (MHC),
which has a strong effect on immune response to viral antigens.9
It is possible that a specific HLA allele(s) or haplotype(s)
prevalent in women might influence the persistence infection.10
Dendritic cells play a central role in promoting cell-mediated
immunity. Infected DCs fail to respond to tumour necrosis
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factor alpha as an additional maturation stimulus and were
found to be apoptotic.10

Conclusion
Any patient with prolonged fever should alert the
physician of other serious infections such as dengue fever,
which may be potentially fatal if not promptly recognized and
treated. From the epidemiology point of view, family members
often manage DF symptomatically, and consequently the
diagnosis of dengue infection will be overlooked, remaining
unreported. The case shows that concurrent infections with
HEV, HAV and DV can possibly change the clinical spectrum
of the disease. This combination is rare but for good outcome,
careful overall assessment is required to help avoid unnecessary
delay in the diagnosis of illness.
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